NHS England to Ban Homeopathy and Herbal Medicine to Save Money

The U.K.’s National Health Service (NHS) has announced that it will ban homeopathy and herbal medicine in order to save £250 million ($325 million) a year, calling the healing methods a “misuse of scarce funds.” They are among dozens of medicines which officials said should not be funded by the health service. [1]

NHS has spent hundreds of thousands of pounds on homeopathic treatment, which it now says “is a placebo” and a waste of money that could be spent on “treatments that work.”

Health officials said the products on the list were “relatively ineffective, unnecessary, inappropriate, or unsafe for prescription on the NHS.”

Moving forward, patients will be told to pay for their own treatment for dozens of common ailments, ranging from indigestion to athlete’s foot. No more homeopathic products like cough and cold treatments, eye drops, or laxatives will be covered by the service.

Additionally, the Department of Health is mulling cutting back spending on gluten-free products.

NHS chief executive Simon Stevens said:

“The NHS is probably the world’s most efficient health service, but like every country there is still waste and inefficiency that we’re determined to root out.

The public rightly expects that the NHS will use every pound wisely, and today we’re taking practical action to free up funding to better spend on modern drugs and treatments.”

Read: Study Suggests Homeopathy “Aided Pain of Cancer Patients Ten Fold”

According to officials, many of the natural health remedies that had been offered by NHS are readily available over the counter in pharmacies, supermarkets, and other stores, and are often priced lower than the cost to NHS.

It might be cheaper for the NHS, but not for low-income patients. Don Redding, National Voices’ director of policy, noted:

“There are many patients who would be unable to afford the remedies over the counter – for example people who are exempt from prescription charges such as the under-16s, people living with cancer, pregnant women and those on low incomes.

Stopping such prescriptions would be tantamount to introducing ‘ability to pay’ as a barrier to accessing the treatments people need. This breaks with the principle of ‘free at the point of use’ guaranteed by the NHS constitution.” [2]

“Ability to pay” refers to forcing patients to pay for other products the NHS claims are “ineffective, overpriced and low-value” instead of giving prescriptions for them.

The NHS constitution states that:

“Access to NHS services is based on clinical need, not an individual’s ability to pay; NHS services are free of charge, except in limited circumstances sanctioned by parliament.”

Read: 1,900 Prescriptions Filled to Britons Every Minute, 1 Billion a Year

Despite the contradiction, experts welcomed the announcement.

Edzard Ernst, emeritus professor of complementary medicine at the University of Exeter, said:

“Homeopathy is based on implausible assumptions and the most reliable evidence fails to show that it works beyond a placebo effect. It can cause severe harm when used as an alternative to effective treatments.

Therefore, it is high time that the NHS stops funding it and instead employs our scarce resources on treatments that are backed by sound science.”

Project director of the Good Thinking Society Michael Marshall stated:

“This is very welcome news. Every credible medical body certainly knows that homeopathic remedies are just not effective for any conditions at all and it is great to see this strong statement from NHS England officially acknowledging the fact.”

However, Professor Helen Stokes-Lampard, chair of the Royal College of GPs, said the ban threatens the health of those most in need. [3]

She explained:

“If patients are in a position that they can afford to buy over the counter medicines and products, then we would encourage them to do so rather than request a prescription – but imposing blanket policies on GPs, that don’t take into account demographic differences across the country, or that don’t allow for flexibility for a patient’s individual circumstances, risks alienating the most vulnerable in society.”

Sources:

[1] The Telegraph

[2] Mirror

[3] Independent


Storable Food


Study: Cannabidiol-Based Medication Reduces Intense Seizures by 50%

Marijuana has been associated with reducing seizures in people with epilepsy for years, but only now is the topic getting more of the scientific scrutiny it deserves. In a recent study, cannabidiol (CBD) reduced the number of seizures by half in a substantial number of children and adults with Lennox-Gastaut syndrome (LGS), a severe form of epilepsy.

GW Pharmaceuticals, a developer of cannabidiol, sponsored the study.

In a press release, study author Dr. Anup Patel, of Nationwide Children’s Hospital and The Ohio State University College of Medicine in Columbus and a member of the American Academy of Neurology, said:

“Our study found that cannabidiol shows great promise in that it may reduce seizures that are otherwise difficult to control. This is important because this kind of epilepsy is incredibly difficult to treat.”

Tracking the Effect of CBD on Seizures

For the study, researchers followed 225 people with LGS for 14 weeks. The participants had an average age of 16 and experienced an average of 85 “drop seizures” (also called atonic seizures) a month.

Read: Cannabis Compounds Reduce Serious Seizures in Children by 53%

These types of seizures result in a loss of muscle tone, causing the person’s head or body to suddenly go limp. Though atonic seizures generally last less than 15 seconds, the loss of muscle tone causes the person to fall to the ground, and they may need to wear a helmet or other form of head protection. [2]

LGS usually first affects patients beginning in childhood, have different types of seizures on a daily basis, and often have learning impairments. [3]

Source: LGS Foundation

The participants had also unsuccessfully tried an average of 6 epilepsy drugs and were taking an average of 3 epilepsy drugs during the study.

  • One group of participants was given 20 mg per kilogram (mg/kg) of cannabidiol daily.
  • A second group received just 10 mg/kg.
  • A third group received a placebo.

On average, the group that took the lower dose of cannabidiol had a 37% decrease in seizures. The participants who took 20 mg/kg saw their seizures decrease by half or more.

The placebo group also saw a decrease – about 17%. About 15% had their seizures decline by half or more.

After doing the math, the researchers concluded that participants in the high-dose group were 2.6 times more likely to report their overall condition had improved compared with the those in the placebo group.

Read: Cannabis Compound Found to Help Rare Forms of Epilepsy

Some 94% of those in the high-dose group and 84% of those in the lower-dose group did experience side effects. About 72% of the placebo group said they, too, had side effects. However, the side effects – including loss of appetite and sleepiness – were mild to moderate. [1] [4]

Patel said:

“Our results suggest that cannabidiol may be effective for those with Lennox-Gastaut syndrome in treating drop seizures. This is important because this kind of epilepsy is incredibly difficult to treat. While there were more side effects for those taking cannabidiol, they were mostly well tolerated. I believe that it may become an important new treatment option for these patients.”

Next, the team plans to seek approval from the FDA to license cannabidiol LGS sometime this year.

The study findings were presented at the American Academy of Neurology’s 69th Annual Meeting in Boston.

Sources:

[1] Healthline

[2] Epilepsy Foundation

[3] Vocativ

[4] UPI

LGS Foundation


Storable Food